Literature DB >> 11062936

Potential of 4 per cent silver fluoride to induce fluorosis in rats: clinical implications.

T Gotjamanos1, P Ma.   

Abstract

The Health Department in Western Australia uses a 40 per cent silver fluoride (AgF) solution for prevention and treatment of dental caries in children. Analysis of this solution has revealed high fluoride concentrations (75,000-120,000 mg/L), raising concerns of potential toxicity and prompting investigation of clinical protocols utilizing low-strength AgF in an animal model. A single topical application of 4 per cent AgF solution to Sprague-Dawley rats resulted in moderate to severe localized fluorosis in 24 per cent of animals. In a second experiment, caries was induced in rats aged 19 days; six weeks later, between one-four carious molar teeth from each rat were treated with 4 per cent AgF (atraumatic technique). A generalized form of fluorosis developed in the continually growing incisors of less than 10 per cent of animals which had one or two carious teeth treated, and in 70-90 per cent of rats which received AgF to either three or four carious teeth. These results confirm the potential of a 4 per cent AgF solution to induce fluorosis and support previous recommendations that AgF at its empirical concentration of 40 per cent should be withdrawn from clinical use.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11062936     DOI: 10.1111/j.1834-7819.2000.tb00555.x

Source DB:  PubMed          Journal:  Aust Dent J        ISSN: 0045-0421            Impact factor:   2.291


  2 in total

1.  UCSF Protocol for Caries Arrest Using Silver Diamine Fluoride: Rationale, Indications and Consent.

Authors:  Jeremy A Horst; Hellene Ellenikiotis; Peter L Milgrom
Journal:  J Calif Dent Assoc       Date:  2016-01

2.  Short term serum pharmacokinetics of diammine silver fluoride after oral application.

Authors:  Elsa Vasquez; Graciela Zegarra; Edgar Chirinos; Jorge L Castillo; Donald R Taves; Gene E Watson; Russell Dills; Lloyd L Mancl; Peter Milgrom
Journal:  BMC Oral Health       Date:  2012-12-31       Impact factor: 2.757

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.